Ecthyma gangrenosum can complicate MOG treatment of SS and is mostly related to the global immunosuppression induced by the disease itself, as CTCL tumoral lymphocytes present a mostly Th2 profile and produce TGF-beta [107]. This evidence concerns the gene MOG and synovial sarcoma.